Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

661 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I study of F16IL2 antibody-cytokine fusion with very low-dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation.
Schliemann C, Kessler T, Berdel AF, Hemmerle T, Angenendt L, Altvater B, Rossig C, Mikesch JH, Lenz G, Schäfers M, Neri D, Stelljes M, Berdel WE. Schliemann C, et al. Among authors: neri d. Br J Haematol. 2021 Mar;192(6):e148-e151. doi: 10.1111/bjh.17365. Epub 2021 Feb 22. Br J Haematol. 2021. PMID: 33618424 Clinical Trial. No abstract available.
Antibody-based targeting of the tumor vasculature.
Schliemann C, Neri D. Schliemann C, et al. Among authors: neri d. Biochim Biophys Acta. 2007 Dec;1776(2):175-92. doi: 10.1016/j.bbcan.2007.08.002. Epub 2007 Aug 25. Biochim Biophys Acta. 2007. PMID: 17920773 Review.
Antibody-based vascular tumor targeting.
Schliemann C, Neri D. Schliemann C, et al. Among authors: neri d. Recent Results Cancer Res. 2010;180:201-16. doi: 10.1007/978-3-540-78281-0_12. Recent Results Cancer Res. 2010. PMID: 20033385 Review.
661 results